HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

2- ((4- (1- methyl- 4- pyridin- 4- yl- 1H- pyrazol- 3- yl)phenoxy)methyl)quinoline

a phosphodiesterase inhibitor
Also Known As:
((11)C)MP-10; (11C)MP-10 cpd; 2-((4-(1-((11)C)methyl-4-(pyridin-4-yl)-1H-pyrazol-3-yl)phenoxy)methyl)-quinoline; MP-10 compound; PF-02545920; PF-2545920; PF-920
Networked: 7 relevant articles (0 outcomes, 2 trials/studies)

Bio-Agent Context: Research Results

Experts

1. DeMartinis, Nicholas: 2 articles (11/2019 - 07/2019)
2. Schmidt, Christopher J: 2 articles (11/2019 - 07/2019)
3. Walling, David P: 2 articles (11/2019 - 07/2019)
4. Bailey, David S: 1 article (09/2021)
5. Kopanitsa, Liliya: 1 article (09/2021)
6. Kopanitsa, Maksym V: 1 article (09/2021)
7. Ladds, Graham: 1 article (09/2021)
8. Safitri, Dewi: 1 article (09/2021)
9. Banerjee, Anindita: 1 article (11/2019)
10. Boyer, Stacey: 1 article (11/2019)

Related Diseases

1. Schizophrenia (Dementia Praecox)
2. Status Epilepticus (Complex Partial Status Epilepticus)
3. Ovarian Neoplasms (Ovarian Cancer)
4. Neoplasms (Cancer)
5. Glioblastoma (Glioblastoma Multiforme)

Related Drugs and Biologics

1. Phosphoric Diester Hydrolases (Phosphodiesterases)
2. Antipsychotic Agents (Antipsychotics)
3. Phosphodiesterase 5 Inhibitors
4. Small Interfering RNA (siRNA)
5. Risperidone (Risperdal Consta)
6. Papaverine
7. Non-Steroidal Anti-Inflammatory Agents (NSAIDs)
8. reversan
9. multidrug resistance-associated protein 1
10. MY 5445

Related Therapies and Procedures

1. Therapeutics